Eyeworld Daily News

2019 ASCRS•ASOA San Diego Daily Saturday

EyeWorld Today is the official daily of the ASCRS Symposium & Congress. Each issue provides comprehensive coverage editorial coverage of meeting presentations, events, and breaking news

Issue link: http://daily.eyeworld.org/i/1116412

Contents of this Issue

Navigation

Page 3 of 98

ASCRS DAILY NEWS S A T U R D AY, M AY 4 , 2 019 | A S C R S A S O A A N N U A L M E E T I N G by Liz Hillman EyeWorld Senior Staff Writer T he 2019 Steinert Refrac- tive Lecture at the 2019 ASCRS Refractive Day was presented by Eric Donnenfeld, MD, Rock- ville Centre, New York. Dr. Donnenfeld has published hundreds of peer-re- viewed papers, participated in more than 60 FDA clinical trials, by Liz Hillman EyeWorld Senior Staff Writer S everal presentations during the 2019 ASCRS Refractive Day covered technologies and innova- tions that could enhance premium refractive lens surgery. An automated capsulotomy device has the ability to create a precise, reproducible capsulor- hexis, but Kevin Waltz, MD, Moving premium refractive lens surgery forward Steinert Refractive Lecture seeks to correct LASIK myths and misconceptions Ocular 1 BVI 1 WHEN RELIABILITY COUNTS THE RIGHT PACK MATTERS bvimedical.com Minimize your pack-building time Expedite your OR experience CustomEyes ® your pack BVI, BVI Logo and all other trademarks (unless noted otherwise) are property of Beaver-Visitec International, Inc. ("BVI") © 2019 BVI. 1498237-03 Visit BVI BOOTH 1206 Dextenza ® BIG TIME'I � ION VISIT BOOTH #1737 1 Sawhney AS, �arrett Bassett M, Blizzard C, inventors; Incept, LLC, assignee Drug delivery through hydrogel plugs. US patent 8,409,606 82. April 2, 2013. © 2019 Ocular Therapeutix, Inc. All rights reserved. DEXTENZA is a registered trademark of Ocular Therapeutix, Inc. I PP-US-DX-0097 FOR FULL PRESCRIBING INFORMATION VISIT DEXTENZA.COM Indianapolis, said there might be secondary, long-term benefits of such technology as well. Dr. Waltz focused his talk on Zepto (Mynosys) because it is the only device FDA-approved in the U.S., but there are other automated capsulotomy devices. Studies have shown a Zep- to-created capsulotomy has a stronger, more tear-resistant edge when compared to femtosecond laser-created and manual capsulo- tomies. Zepto has also been asso- ciated with a reduced PCO rate, which Dr. Waltz said was "totally continued on page 4 continued on page 3 Dr. Holland presents Dr. Donnenfeld (left) with the Steinert Refractive Lecture award. unexpected" and could be due to "markedly reduced fibrosis inside the capsule." Five-year data, Dr. Waltz said, suggests that with less intracapsular fibrosis you could have less phimosis long-term. With these, Dr. Waltz said there "might be some hidden ben- efits to automated capsulotomies." Nuclear disassembly with miLOOP (Carl Zeiss Meditec) can have refractive benefits, said Sean Ianchulev, MD, New York. Dr. Ianchulev described research that suggests the cen- tripetal fragmentation that avoids stretching the capsular bag (unlike traditional centrifugal phaco-chop techniques) impacts effective lens position. This benefit is in addi- tion to the reduced phaco energy delivered to the eye for nuclear disassembly. In terms of innovation of premium lenses, Robert Maloney, MD, Los Angeles, highlighted the Light Adjustable Lens (RxSight). This lens is implanted in basic cataract surgery with no LRIs, no corneal marking, no intraop- erative aberrometry, and no axis

Articles in this issue

Links on this page

Archives of this issue

view archives of Eyeworld Daily News - 2019 ASCRS•ASOA San Diego Daily Saturday